November 26, 2014Stroke139 citationsOpen Access
View Full PaperStroke and Major Bleeding Risk in Elderly Patients Aged ≥75 Years With Atrial Fibrillation
Structured PICO
Does VKA therapy reduce stroke/thromboembolism or mortality in elderly patients aged ≥75 years with atrial fibrillation?
P
Population
Elderly patients aged ≥75 years with atrial fibrillation
I
Intervention
VKA therapy
O
Outcome
Stroke/thromboembolism or mortalityhard clinical
VKA therapy remains beneficial for reducing stroke and mortality in AF patients aged ≥75 years, despite their higher baseline bleeding risk.
Abstract
Elderly patients with AF have a higher risk of stroke and bleeding, but the benefits of VKA therapy for stroke/thromboembolism or mortality were present regardless of increasing age.